GE to sell biopharma unit to Danaher for $21.4 billion

28-02-2019

GE to sell biopharma unit to Danaher for $21.4 billion

JPstock / Shutterstock.com

General Electric (GE) will sell its biopharma business, which generated $3 billion in revenues for the conglomerate last year, to Danaher in a $21.4 billion deal.


General Electric, life sciences, biopharma, biopharmaceutical drugs, Danaher, agreement of sale

LSIPR